1. Luxembourg Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Eurofins Scientific SE

Eurofins Scientific SE

ESF.VI
Eurofins Scientific SEAT flagVienna Stock Exchange
61.38
EUR
+0.04
- -
10.72BMarket Cap

Total Valuation

Eurofins Scientific SE carries a market capitalization of 10.72B, placing it among publicly traded companies globally. Its enterprise value stands at 260.05M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap10.72B
Enterprise Value260.05M

Share Statistics

Eurofins Scientific SE currently has 143.55M shares outstanding.

Shares Outstanding143.55M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Enterprise Valuation

On an enterprise value basis, Eurofins Scientific SE trades at an EV/EBITDA multiple of 2.87 and an EV/FCF ratio of 1.46. The EV/Sales ratio of 0.31 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 2.87 provides insight into valuation relative to core operating earnings.

EV / Sales0.31
EV / EBITDA2.87
EV / EBIT2.87
EV / FCF1.46

Financial Position

Eurofins Scientific SE maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 135.70, indicating elevated leverage, while an interest coverage ratio of 5.13 demonstrates adequate ability to service its debt obligations.

Current Ratio1.56
Quick Ratio0.63
Debt / Equity135.70
Debt / EBITDA4.79
Interest Coverage5.13

Financial Efficiency

Eurofins Scientific SE posts a return on equity of 77.74 and a return on invested capital of 10.71.

Return on Equity (ROE)77.74
Return on Assets (ROA)6.26
Return on Invested Capital (ROIC)10.71
Return on Capital Employed (ROCE)16.62
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover32.09

Taxes

Over the trailing twelve months, Eurofins Scientific SE has paid 13.82M in income taxes, reflecting an effective tax rate of 19.61.

Income Tax13.82M
Effective Tax Rate19.61

Stock Price Statistics

Eurofins Scientific SE's stock has gained approximately 6.15704% over the past 52 weeks. The 50-day moving average sits at 62.50, while the 200-day moving average is 63.37.

Beta (5Y)N/A
52-Week Price Change6.15704%
50-Day Moving Average62.50
200-Day Moving Average63.37
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Eurofins Scientific SE generated 828.94M in revenue and converted that into 56.65M in net income, yielding earnings per share of 0.36. EBITDA reached 90.76M, while operating income came in at 90.76M.

Revenue828.94M
Gross Profit534.69M
Operating Income90.76M
Pretax Income70.46M
Net Income56.65M
EBITDA90.76M
EBIT90.76M
Earnings Per Share (EPS)0.36

Balance Sheet

Eurofins Scientific SE holds 179.49M in cash and equivalents against 434.68M in total debt, resulting in a net debt position of 251.63M. Total book value stands at 86.96M, with working capital of 158.93M providing operational flexibility.

Cash & Cash Equivalents179.49M
Total Debt434.68M
Net Debt251.63M
Equity (Book Value)86.96M
Book Value Per Share0.61
Working Capital158.93M

Cash Flow

Eurofins Scientific SE produced 110.32M in operating cash flow over the past twelve months. After subtracting -53.91M in capital expenditures, free cash flow totaled 56.42M - equivalent to 0.39 per share.

Operating Cash Flow110.32M
Capital Expenditures-53.91M
Free Cash Flow56.42M
FCF Per Share0.39

Margins

Eurofins Scientific SE operates with a gross margin of 64.50, reflecting its pricing power and cost economics. The operating margin of 10.95 and net profit margin of 6.83 provide insight into operational efficiency.

Gross Margin64.50
Operating Margin10.95
Pretax Margin8.50
Profit Margin6.83
EBITDA Margin10.95

Stock Splits

Eurofins Scientific SE's most recent stock split took place on November 19, 2020 with a 1:10 split ratio.

Last Split Date11/19/2020
Split Ratio1:10

Scores

Eurofins Scientific SE posts an Altman Z-Score of 2.26, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.26